Results 221 to 230 of about 9,696,955 (392)

Interleukin-6 as a potential biomarker of COVID-19 progression

Médecine et maladies infectieuses, 2020
Z. S. Ulhaq, G. Soraya
semanticscholar   +1 more source

Low‐Temperature Fabrication of Thymosin β4‐Loaded Soluble Microneedles to Promote Wound Healing by Specific Binding to Downregulated Immune Regulators Vsig4 and IL22rɑ2

Advanced Healthcare Materials, EarlyView.
Schematic diagram depicting the fabrication and application of thymosin β4 (Tβ4)‐loaded microneedle patches for wound treatment. The Tβ4 was loaded into chitosan (CS) and sucrose MNs under mild conditions (4°C, 65% relative humidity). The Tβ4 MN patch specifically binds to the downregulated immune regulators Vsig4 and IL22rα2, thereby accelerating ...
Shilong He, Mei Yuan, Changkang Feng, Yixuan Zhang, Jinjing Che   +4 more
wiley   +1 more source

Treatment of severe covid-19 with interleukin 6 receptor inhibition

BMJ Medicine, 2022
Stephen Burgess, Dipender Gill, Skanda Rajasundaram   +2 more
doaj   +1 more source

Genetic Downregulation of Interleukin-6 Signaling, Coagulation Function, and Risk of Thromboembolic Disease. [PDF]

J Am Heart Assoc
Daghlas I, Gill D.
europepmc   +1 more source

MicroRNA-497 regulates the proliferation of clear cell renal cell carcinoma via interleukin-6 receptor [PDF]

, 2019
Caixia Gao, Yanxia Li, Lin Liu
openalex   +1 more source

Automating Vascular Biology: An End‐to‐End Automated Workflow for High‐Throughput Blood Vessel‐on‐a‐Chip Production and Multi‐Site Validation

Advanced Healthcare Materials, EarlyView.
AngioPlate384 is a 384‐well open‐top platform that automates production of more than 100 miniaturized, perfusable blood vessels embedded in hydrogel and supported by stromal cells. Stromal‐endothelial co‐culture strengthens blood vessel barrier function and yields responses useful for translational planning. Scalable and automation‐ready, it suits drug
Dawn S. Y. Lin, Hanieh Mohammad Hashemi, Kimia Asadi Jozani, Anushree Chakravarty, Sonya Kouthouridis, Jessica Bonanno, Nicky Anvari, Shravanthi Rajasekar, Feng Zhang, Richard Y. Cheng, Narendra Kumar Singh, Luis Miguel Medina, Marc Durante, Yufang He, Boyang Zhang   +14 more
wiley   +1 more source

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis

Central European Journal of Immunology, 2019
Tomasz Kaczyński, Jakub Wroński, Piotr Głuszko, Tomasz Kryczka, Andrzej Miskiewicz, Bartłomiej Górski, Marek Radkowski, Damian Strzemecki, Paweł Grieb, Renata Górska   +9 more
doaj   +1 more source

Engineered ETS1‐Nanoconjugate Restores Immune Homeostasis through Dual Immune‐Vascular Modulation in Relapsing and Progressive Multiple Sclerosis

Advanced Healthcare Materials, EarlyView.
The biomimetic nanoplatform IMNP (ETS1 pDNA/PBAE@ITP‐MM) undergoes targeted disassembly at inflammatory vascular sites to release the ETS1 plasmid (pETS1). This release initiates a cascade of effects that inhibit pathogenic pathways and support immune homeostasis. (Abbreviations: EndMT, endothelial‐to‐mesenchymal transition; EC, endothelial cell; TC, T
Feng Zhang, Si‐Bo Yang, Yan Luo, Xiao‐Di Sun, Bo‐Hao Chang, Da‐Qiang Zhou, Jun‐Jie Jiang, Ya‐Nan Li, Jie‐Hong Wu, Hui‐Juan Jin, Hang Yang, Hang Hu, Yi‐Fan Zhou, Bo Hu   +13 more
wiley   +1 more source

Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines.

Immunity, 2019
M. Murakami, D. Kamimura, T. Hirano
semanticscholar   +1 more source

Interleukin-6 as prognosticator in patients with COVID-19

Journal of Infection, 2020
E. Grifoni, Alice Valoriani, F. Cei, Roberta Lamanna, A. M. G. Gelli, Benedetta Ciambotti, V. Vannucchi, F. Moroni, L. Pelagatti, R. Tarquini, G. Landini, S. Vanni, L. Masotti   +12 more
semanticscholar   +1 more source